186 related articles for article (PubMed ID: 19029443)
1. Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation.
Veljkovic DK; Rivard GE; Diamandis M; Blavignac J; Cramer-Bordé EM; Hayward CP
Blood; 2009 Feb; 113(7):1535-42. PubMed ID: 19029443
[TBL] [Abstract][Full Text] [Related]
2. Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes.
Diamandis M; Paterson AD; Rommens JM; Veljkovic DK; Blavignac J; Bulman DE; Waye JS; Derome F; Rivard GE; Hayward CP
Blood; 2009 Feb; 113(7):1543-6. PubMed ID: 18988861
[TBL] [Abstract][Full Text] [Related]
3. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator.
Kahr WH; Zheng S; Sheth PM; Pai M; Cowie A; Bouchard M; Podor TJ; Rivard GE; Hayward CP
Blood; 2001 Jul; 98(2):257-65. PubMed ID: 11435291
[TBL] [Abstract][Full Text] [Related]
4. The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes.
Hayward CP; Liang M; Tasneem S; Soomro A; Waye JS; Paterson AD; Rivard GE; Wilson MD
PLoS One; 2017; 12(3):e0173991. PubMed ID: 28301587
[TBL] [Abstract][Full Text] [Related]
5. Intracellular activation of the fibrinolytic cascade in the Quebec Platelet Disorder.
Sheth PM; Kahr WH; Haq MA; Veljkovic DK; Rivard GE; Hayward CP
Thromb Haemost; 2003 Aug; 90(2):293-8. PubMed ID: 12888877
[TBL] [Abstract][Full Text] [Related]
6. Quebec platelet disorder: features, pathogenesis and treatment.
Diamandis M; Veljkovic DK; Maurer-Spurej E; Rivard GE; Hayward CP
Blood Coagul Fibrinolysis; 2008 Mar; 19(2):109-19. PubMed ID: 18277131
[TBL] [Abstract][Full Text] [Related]
7. Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment.
Blavignac J; Bunimov N; Rivard GE; Hayward CP
Semin Thromb Hemost; 2011 Sep; 37(6):713-20. PubMed ID: 22102275
[TBL] [Abstract][Full Text] [Related]
8. Insights into abnormal hemostasis in the Quebec platelet disorder from analyses of clot lysis.
Diamandis M; Adam F; Kahr WH; Wang P; Chorneyko KA; Arsenault AL; Rivard GE; Hayward CP
J Thromb Haemost; 2006 May; 4(5):1086-94. PubMed ID: 16689763
[TBL] [Abstract][Full Text] [Related]
9. Quebec platelet disorder.
Hayward CP; Rivard GE
Expert Rev Hematol; 2011 Apr; 4(2):137-41. PubMed ID: 21495923
[TBL] [Abstract][Full Text] [Related]
10. Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene.
Paterson AD; Rommens JM; Bharaj B; Blavignac J; Wong I; Diamandis M; Waye JS; Rivard GE; Hayward CP
Blood; 2010 Feb; 115(6):1264-6. PubMed ID: 20007542
[TBL] [Abstract][Full Text] [Related]
11. Enhancer-gene rewiring in the pathogenesis of Quebec platelet disorder.
Liang M; Soomro A; Tasneem S; Abatti LE; Alizada A; Yuan X; Uusküla-Reimand L; Antounians L; Alvi SA; Paterson AD; Rivard GÉ; Scott IC; Mitchell JA; Hayward CPM; Wilson MD
Blood; 2020 Dec; 136(23):2679-2690. PubMed ID: 32663239
[TBL] [Abstract][Full Text] [Related]
12. Thrombin generation abnormalities in Quebec platelet disorder.
Brunet JG; Sharma T; Tasneem S; Liang M; Wilson MD; Rivard GE; Hayward CPM
Int J Lab Hematol; 2020 Dec; 42(6):801-809. PubMed ID: 32761872
[TBL] [Abstract][Full Text] [Related]
13. Activated platelets increase fibrinolysis of mesenchymal progenitor cells.
Agis H; Kandler B; Fischer MB; Watzek G; Gruber R
J Orthop Res; 2009 Jul; 27(7):972-80. PubMed ID: 19030175
[TBL] [Abstract][Full Text] [Related]
14. Inherited disorders of the fibrinolytic pathway.
Jain S; Acharya SS
Transfus Apher Sci; 2019 Oct; 58(5):572-577. PubMed ID: 31427261
[TBL] [Abstract][Full Text] [Related]
15. Packaging of supplemented urokinase into naked alpha-granules of
Poncz M; Zaitsev SV; Ahn H; Kowalska MA; Bdeir K; Camire RM; Cines DB; Stepanova V
bioRxiv; 2023 Dec; ():. PubMed ID: 38106191
[TBL] [Abstract][Full Text] [Related]
16. Unraveling mechanisms that control platelet production.
Italiano JE
Semin Thromb Hemost; 2013 Feb; 39(1):15-24. PubMed ID: 23266965
[TBL] [Abstract][Full Text] [Related]
17. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage.
Wohn KD; Kanse SM; Deutsch V; Schmidt T; Eldor A; Preissner KT
Thromb Haemost; 1997 Mar; 77(3):540-7. PubMed ID: 9066008
[TBL] [Abstract][Full Text] [Related]
18. Megakaryocytes and platelets in alpha-granule disorders.
Smith MP; Cramer EM; Savidge GF
Baillieres Clin Haematol; 1997 Feb; 10(1):125-48. PubMed ID: 9154319
[TBL] [Abstract][Full Text] [Related]
19. Packaging of supplemented urokinase into alpha-granules of in vitro-grown megakaryocytes for targeted nascent clot lysis.
Poncz M; Zaitsev S; Ahn H; Kowalska MA; Bdeir K; Dergilev KV; Ivanciu L; Camire RM; Cines DB; Stepanova V
Blood Adv; 2024 May; ():. PubMed ID: 38805575
[TBL] [Abstract][Full Text] [Related]
20. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
Wells JM; Strickland S
J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
